DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), ...

Net Loan-To-Value (LTV) -- 34.5% with a target net LTV range of 20%-25% stated by management. Available Liquidity -- $412 million reported as of quarter-end. Contracted Revenue Backlog -- $3.7 billion ...

Q3 2025 Earnings Call November 18, 2025 4:00 AM ESTCompany ParticipantsJonas Warrer - Chief Executive OfficerMads Albrechtsen ...

Having found swift success with its Jazz Pharmaceuticals and BeOne Medicines-licensed cancer med Ziihera, Zymeworks has ...

Chevron said on Wednesday that it plans to grow free cash flow by more than 10% annually through 2030 and increase oil and ...

Bolt Projects Holdings, Inc. (Nasdaq: BSLK), a developer of biomaterials for the beauty and personal care industry, reported financial results for the third quarter ended September 30, 2025.

At its investor day, Chevron Corporation (NYSE: CVX) outlined its five-year plan to 2030 and how it intends to deliver sustained cash flow growth, further strengthen its portfolio, advance power ...

Prices $7.4 Million Common Stock Offering to Accelerate Growth Debt Free Company Strengthens Balance Sheet Ahead of Expected Cash Flow Positive ...

For the three and nine months ended September 30, 2025, this relates to payments related to our corporate re-brand and other non-recurring fees. For the three and nine months ended September 30, 2024, ...

Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment. MCLEAN, VA / ACCESS Newswire / November 3, 2025 / Gladstone ...

2025 Guidance Update -- Revenue guidance set at $870 million to $880 million and adjusted EBITDA guidance set at $164 million ...

Krispy Kreme Inc. generated positive cash from operations in the third quarter for the first time in three quarters — and its ...